Trump Pauses Disbursement of Global HIV Treatment Funds
By Stephanie Brown HealthDay Reporter
MONDAY, Jan. 27, 2025 -- The Trump administration has paused funding for a crucial HIV treatment program in Africa and developing countries for 90 days, according to a memo obtained by The New York Times.
The directive stems from President Trump's executive order on foreign aid, in which all government divisions with foreign development assistance programs have been ordered to stop disbursing funds. Initial review of foreign aid is intended to be completed within 85 days; however, final decisions might take up to 180 days.
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), a $7.5 billion program under the governance of the State Department, was due for a five-year reauthorization in 2023. After avoiding a Republican effort to end the program, it was renewed for one year, according to The Times.
Many public health and development experts are dismayed at this hold on funding.
"Any prolonged pause in funding could disrupt HIV treatment programs, leading to treatment interruptions, rise of drug-resistant HIV," Jirair Ratevosian, Ph.D., who served as chief of staff for PEPFAR during the Biden administration, told The Times. "That's playing with fire, risking progress that we've made over decades to control the HIV epidemic." Ratevosian added that resistant strains of the virus that may emerge in other nations would also be of great concern to Americans.
The New York Times Article
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Eight Times More Young Adults Take Meds To Protect Against HIV Infection
FRIDAY, May 30, 2025 — Eight times more young Americans are taking antiretroviral meds to protect them from HIV infection than a decade ago, a new study says. About 208 of...
HIV Pills Might Prevent Alzheimer's
TUESDAY, May 13, 2025 — Drugs that battle HIV and hepatitis B might be able to help people avoid Alzheimer’s disease, a new study says. Nucleoside reverse...
$800M in LGBTQ Health Research Funding Nixed by Trump Administration
TUESDAY, May 6, 2025 — The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies on cancer, HIV and other...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.